Literature DB >> 8790377

Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport.

Y Li1, J J Bergeron, L Luo, W J Ou, D Y Thomas, C Y Kang.   

Abstract

The HIV-1 envelope glycoprotein gp120 displays inefficient intracellular transport, which is caused by its retention in the endoplasmic reticulum. Coexpression in insect cells (Sf9) of HIV-1 gp120 with calnexin has shown that their interaction was modulated by the signal sequence of HIV-1 gp120. gp120, with its natural signal sequence, showed a prolonged association with calnexin with a t1/2 of greater than 20 min. Replacement of the natural signal sequence with the signal sequence from mellitin led to a decreased time of association of gp120 with calnexin (t1/2 < 10 min). These different times of calnexin association coincided both with the folding of gp120 as measured by the ability of bind CD4 and with endoplasmic reticulum to Golgi transport as analyzed by the acquisition of partial endoglycosidase H resistance. Using a monospecific antibody to the HIV-1 gp120 natural signal peptide, we showed that calnexin associated with N-glycosylated but uncleaved gp120. Only after dissociation from calnexin was gp120 cleaved, but very inefficiently. Only the small proportion of signal-cleaved gp120 molecules acquired transport competence and were secreted. This is the first report demonstrating the effect of the signal sequence on calnexin association.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790377      PMCID: PMC38475          DOI: 10.1073/pnas.93.18.9606

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.

Authors:  P W Berman; W M Nunes; O K Haffar
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

2.  Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein.

Authors:  L A Lasky; J E Groopman; C W Fennie; P M Benz; D J Capon; D J Dowbenko; G R Nakamura; W M Nunes; M E Renz; P W Berman
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

Authors:  J R Rusche; D L Lynn; M Robert-Guroff; A J Langlois; H K Lyerly; H Carson; K Krohn; A Ranki; R C Gallo; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Expression of envelope glycoproteins of human immunodeficiency virus by an insect virus vector.

Authors:  S I Hu; S G Kosowski; K F Schaaf
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

6.  Control of expression, glycosylation, and secretion of HIV-1 gp120 by homologous and heterologous signal sequences.

Authors:  Y Li; L Luo; D Y Thomas; C Y Kang
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.

Authors:  R L Dewar; V Natarajan; M B Vasudevachari; N P Salzman
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.

Authors:  A M Prince; B Horowitz; L Baker; R W Shulman; H Ralph; J Valinsky; A Cundell; B Brotman; W Boehle; F Rey
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more
  31 in total

1.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.

Authors:  Tommy Tong; Ema T Crooks; Keiko Osawa; James M Binley
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  FXYD3 (Mat-8), a new regulator of Na,K-ATPase.

Authors:  Gilles Crambert; Ciming Li; Dirk Claeys; Käthi Geering
Journal:  Mol Biol Cell       Date:  2005-03-02       Impact factor: 4.138

Review 4.  Protein folding in the endoplasmic reticulum.

Authors:  Ineke Braakman; Daniel N Hebert
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

5.  Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin.

Authors:  B Martoglio; R Graf; B Dobberstein
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

6.  Ubiquitination of the human immunodeficiency virus type 1 env glycoprotein.

Authors:  A Bültmann; J Eberle; J Haas
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal.

Authors:  Tim Angelotti; David Daunt; Olga G Shcherbakova; Brian Kobilka; Carl M Hurt
Journal:  Traffic       Date:  2010-01-06       Impact factor: 6.215

8.  Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.

Authors:  Kelly Stefano Cole; Jonathan D Steckbeck; Jennifer L Rowles; Ronald C Desrosiers; Ronald C Montelaro
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Optimization of human immunodeficiency virus type 1 envelope glycoproteins with V1/V2 deleted, using virus evolution.

Authors:  Ilja Bontjer; Aafke Land; Dirk Eggink; Erwin Verkade; Kiki Tuin; Chris Baldwin; Georgios Pollakis; William A Paxton; Ineke Braakman; Ben Berkhout; Rogier W Sanders
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

10.  Human endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from Rec.

Authors:  Alessia Ruggieri; Esther Maldener; Marlies Sauter; Nikolaus Mueller-Lantzsch; Eckart Meese; Oliver T Fackler; Jens Mayer
Journal:  Retrovirology       Date:  2009-02-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.